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Mosaic mutant analysis, the study of cellular defects
in scattered mutant cells in a wild-type environment,
is a powerful approach for identifying critical func-
tions of genes and has been applied extensively to
invertebrate model organisms. A highly versatile
technique has been developed in mouse: MASTR
(mosaic mutant analysis with spatial and temporal
control of recombination), which utilizes the in-
creasing number of floxed alleles and simultaneously
combines conditional gene mutagenesis and cell
marking for fate analysis. A targeted allele (R26MASTR)
was engineered; the allele expresses a GFPcre
fusion protein following FLP-mediated recombina-
tion, which serves the dual function of deleting floxed
alleles and marking mutant cells with GFP. Within
24 hr of tamoxifen administration to R26MASTR mice
carrying an inducible FlpoER transgene and a floxed
allele, nearly all GFP-expressing cells have a mutant
allele. The fate of single cells lacking FGF8 or SHH
signaling in the developing hindbrain was analyzed
using MASTR, and it was revealed that there is only
a short time window when neural progenitors require
FGFR1 for viability and that granule cell precursors
differentiate rapidly when SMO is lost. MASTR
is a powerful tool that provides cell-type-specific
(spatial) and temporal marking of mosaic mutant
cells and is broadly applicable to developmental,
cancer, and adult stem cell studies.INTRODUCTION
In order to study the full repertoire of in vivo functions of a gene
and to effectively model certain human diseases, it is necessary
to generate tissue-specific conditional mutants at defined times
during development, disease progression, or homeostasis. Con-
ditional mutagenesis in mouse can circumvent the lethality
caused by germline null mutations and allow the primary function386 Cell Reports 2, 386–396, August 30, 2012 ª2012 The Authorsof a gene to be determined in a specific organ or cell type without
potential confounding secondary effects in other tissues.
Furthermore, becausemany genes playmultiple sequential roles
in organ development, temporal control of conditional mutagen-
esis is a means to determine each distinct gene requirement.
Although the introduction of site-specific recombinases and their
target sequences into the mouse genome has allowed for condi-
tional mutagenesis, there remain a number of limitations with the
existing technology.
Mosaic mutant analysis is a powerful innovation applied to
studies in model organisms that allows the behaviors of indi-
vidual mutant cells to be analyzed in a wild-type (WT) cellular
environment, and distinguishes the cell-autonomous functions
of genes. In Drosophila the elegant MARCM (mosaic analysis
with a repressible cell marker) approach combined with mutant
alleles has revolutionized studies of cellular gene function by
allowing mutant cells to be induced and marked in specific
tissues at a defined time point using the FLP site-specific recom-
binase (Lee et al., 2000). A similar approach has been engineered
in mice (MADM; mosaic analysis with double markers) and
involves rare interchromosomal recombination events induced
by CRE recombinase that produce a small number of cells
marked with GFP (Zong et al., 2005). If a null allele resides on
the same chromosome as the engineered reporter components
of the MADM system, then mosaic mutant studies can be per-
formed (Muzumdar et al., 2007). However, the most widely
used method for conditional mutagenesis in mice involves
combining a ‘‘floxed’’ allele in which a critical region of a gene
is flanked by two loxP sites: the target of CRE, and a transgene
expressing CRE in a specific organ or cell type. In order to knock
out a gene at a particular time point, inducible forms of CRE have
been developed, such as CreERT2 that is active for 48 hr
following tamoxifen (Tm) administration (Feil et al., 1997). How-
ever, a frequent problem faced in interpreting the phenotypes
produced through conditional mutagenesis approaches, espe-
cially with CreER alleles, is that not all cells in a given tissue
undergo recombination, and the mosaic mutant cells are often
indistinguishable from WT cells. A CRE recombination-depen-
dent reporter allele can be included along with the conditional
allele; however, the approach is not applicable to Cre lines
with transient expression or for temporal conditional mutagen-
esis with CreER because there is a poor correlation between
reporter expression andmutation. Depending on the recombina-
tion efficiency at each conditional loxP locus, either the reporter
or floxed gene of interest will recombine more frequently, result-
ing in a large number ofmarked cells that areWT (false positives),
or unmarked mutant cells (false negatives), confounding inter-
pretation of the mutant cellular phenotype. Thus, a new tech-
nique for mosaic mutant analysis would be of high impact to
the mouse genetics field.
An ideal mosaic approach in mice would utilize the rapidly
growing number of floxed conditional alleles. Indeed, floxed
alleles for the majority of mouse genes will soon be available
as a result of large-scale genomics efforts in several countries
(Ringwald et al., 2011; Skarnes et al., 2011). The SLICK (single-
neuron labeling with inducible cre-mediated knockout) approach
was developed with this in mind but is limited to differentiated
neurons that have high-level and sustained Thy1 transgene
expression (Heimer-McGinn and Young, 2011). Although this
approach could be extended to other organs, tissue-specific
promoters that continue to express CreER and YFP in themutant
cells of interest after recombination will be difficult to identify.
Expression of both CRE and GFP using viral vectors or electro-
poration has been exploited for mosaic mutant analysis, but
the approach is extremely limited to accessible organs and
particular stages of development. We have addressed these
deficiencies in conditional mouse mosaic mutant analysis by
developing a method for sequentially marking and mutating
any cell harboring a floxed gene at any time during development
or in the adult.
RESULTS
Mosaic Mutant Analysis with Spatial and Temporal
Control of Recombination Approach
In order to develop a highly versatile method for mosaic mutant
analysis in mouse, we reasoned that the method should utilize
the extensive resource of floxed genes, and incorporate tissue-
specific and temporal control over mutagenesis as well as
reliable detection of mutant cells. Given the proven effectiveness
of fluorescent proteins, we developed an approach involving
obligate sequential marking and mutation of mosaic cells. In
the technique, FLP-mediated site-specific recombination leads
to sustained expression of a protein fusion between GFP and
CRE (referred to as GFPcre), which leads to both rapid and
efficient recombination of any floxed gene in a cell and results
in permanent visualization of the mutant cells based on GFP.
We term our approach mosaic mutant analysis with spatial
and temporal control of recombination, or MASTR (Figures 1A
and 1B).
Using gene targeting, we generated a ROSA26 allele
(R26MASTR; Figure S1A) in which a neo gene cassette including
a strong polyadenylation sequence from the Pgk gene (acting
as a STOP of transcription/translation) flanked by frt sites pre-
cedes a cDNA encoding GFPcre (Le et al., 1999) and an SV40
polyadenylation sequence (Bai and Joyner, 2001). Because the
R26 allele is expressed ubiquitously, when the R26MASTR allele
undergoes FLP-mediated recombination of the frt-flanked neo
cassette, this results in continuous GFPcre expression in the
cell and all its descendents. The MASTR approach entails twoadditional genetic alleles: an inducible Flp transgene or knockin,
and a floxed gene. When R26MASTR and an inducible Flp allele
are combined with any floxed gene, then following adminis-
tration of the inducing agent GFPcre will be expressed from
the recombined R26MASTR allele and result in rapid deletion of
the floxed gene creating mosaic mutant cells (Figure 1B). Impor-
tantly, the mutant cells and their progeny can be identified by
continuous GFP expression from the R26 allele.
We first tested whether the R26MASTR allele undergoes
efficient FLP-mediated recombination and expresses GFP
robustly, by using an existing FlpER line (CAG-FlpeERT2) active
in the embryo (Hunter et al., 2005). Indeed, CAG-FlpeER/+;
R26MASTR/+ embryos treated with a high dose of Tm (225 mg/g)
at embryonic day 9.5 (E9.5) and analyzed at E13.5 by immuno-
histochemical (IHC) staining for GFP showed scattered GFP+
cells throughout the embryo (Figure 1C; data not shown).
Analysis of adult brain tissue at high-power magnification
demonstrated that as expected (Le et al., 1999) the majority of
GFPwas localized to the nucleus, and a low level of GFP expres-
sion was detected in the cell body and processes (axons of
neurons; Figure 1D). Furthermore, native GFP fluorescence
could be visualized in fixed tissue sections without IHC (Fig-
ure 1E), indicating that GFP expressed from the recombined
R26MASTR allele can be used for live-imaging analysis of mutant
cell behaviors.
Validation of MASTR Technique
Two important criteria must be met for the MASTR approach to
be effective formosaicmutant analysis. First, theR26MASTR allele
must have a very low level of illegitimate GFPcre expression in
the absence of FLP activity. Second, nearly all GFP+ cells
must undergo CRE-mediated deletion of an accompanying
floxed gene. To validate that our R26MASTR allele meets
these criteria, the R26lox-STOP-lox-lacZ (R26lox-lacZ) reporter allele
(Soriano, 1999) was used to mimic a floxed mutant gene (Fig-
ure 2A). As predicted, cells expressing lacZ (b-galactosidase
[b-gal] activity) were detected throughout the brain of CAG-
FlpeER/+; R26MASTR/lox-lacZ mice following administration of
a high dose of Tm at either embryonic or adult stages (Figure 2B;
data not shown).
To determine whether functional GFPcre is spuriously ex-
pressed in somatic cells from the R26MASTR allele in the absence
of FLP-mediated recombination, we examined b-gal activity in
sections of R26MASTR/lox-lacZ adult mice (n = 5) generated by
breeding mice carrying the R26MASTR allele with those carrying
the R26lox-lacZ reporter allele. Significantly, only rare cells were
b-gal+ in adult mice (0–60 cells per sagittal section of an entire
brain; n = 138 sections from 5 mice; Figures 2C and 2D). The
b-gal+ cells in a section were often seen in clusters, likely reflect-
ing clonal marking of a common ancestor. As expected, in
R26lox-lacZ/+ control mice no b-gal activity was detected (data
not shown). A smaller number of b-gal+ cells were detected
in sections of whole R26MASTR/lox-lacZ embryos (E9.5–E13.5)
(0–13 cells/section; n = 9). Double IHC labeling for GFP and
b-gal protein in R26MASTR/lox-lacZ embryonic tissues uncovered
that none of the b-gal+ cells also expressed GFPcre (Figure 2E).
These results demonstrate that only the occasional cell tran-
siently expresses GFPcre from the R26MASTR allele duringCell Reports 2, 386–396, August 30, 2012 ª2012 The Authors 387
Figure 1. Mosaic MASTR Strategy
(A) Schematic showing MASTR allele.
(B) Schematic of genetic events leading to
temporally controlled marking of cells with GFP
and mutating an endogenous floxed gene with
CRE (GFPcre) following inducible FLP-mediated
recombination using a ubiquitously expressed
inducible Flp line described in Figure 5, R26FlpoER,
that utilizes ERT2. GeneX represents a floxed gene
of interest, in this case a gene expressing protein
X. ‘‘CRE active’’ refers to cells in which the level of
CRE is sufficient and the nature of the floxed allele
is such that it is accessible to being recombined.
Pgk-neo-pA and neo; Pgk promoter fragment
driving expression of the bacterial neomycin
gene followed by a strong Pgk polyadenylation
sequence that acts to inhibit expression of
GFPcre; SA, splice acceptor; pA, three copies of
an SV40 polyadenylation sequence.
(C) IHC detection of GFP (green) in sagittal section
of E13.5 CAG-FlpeER/+; R26MASTR/+ embryo ad-
ministered with Tm (225 mg/g) at E9.5. Low-
magnification image shows a region of the body
containing the heart (h), liver (lv), and lungs (lu) (red
arrow,GFP+ in liver), and inset showsmid-hindbrain
of the same section including the cerebellum (cb).
(D) Similar analysis of adult CAG-FlpeER/+;
R26MASTR/+ mouse administered with Tm (three
doses of 250 mg/g) 3 weeks earlier. High-magni-
fication image of the brain counterstained with
DAPI (blue) showing GFP accumulation primarily
in the nucleus (white arrowheads) and at low levels
in the axon (red arrowheads).
(E) A 12 mm section of a cerebellum lobule imaged
immediately after cryostat sectioning (after 30 min
fixation) from a P7 CAG-FlpeER/+; R26MASTR/+
mouse administered with Tm (150 mg/g) on P1.
GFP+ cells (green) can be readily detected using
a GFP fluorescence filter on a Leica DM6000
microscope.
Scale bars represent 400 mm (C, including inset),
30 mm (D), and 100 mm (E).
See Figures S1 and S2.embryonic development or in the adult. Importantly, because
GFPcre is only transiently expressed, any rare mutant cells re-
sulting from deletion of an accompanying floxed gene at an
undetermined time point will not express GFP and, therefore,
will not be considered as mutant cells. Such mutant cells are
false negatives, and importantly, their rate of production is
negligible.
We next tested whether the R26MASTR allele expresses
GFPcre in the germline, by breeding R26MASTR/lox-lacZ mice
with WT mice, and detecting b-gal+ cells in E10.5 embryos.
Surprisingly, all R26+/lox-lacZ embryos generated from
R26MASTR/lox-lacZ males showed b-gal activity in all cells of the
embryo, whereas all R26+/lox-lacZ embryos generated from
R26MASTR/lox-lacZ females had no b-gal+ cells (data not shown).
Because the R26MASTR allele in R26MASTR/+ embryos from
R26MASTR/lox-lacZmales had not undergone spontaneous recom-
bination (based on PCR genotyping and staining for GFP; data
not shown), the R26MASTR allele must spuriously express
GFPcre in the male germline. Indeed, testes sections from
R26MASTR/lox-lacZ males had b-gal+ cells in the germ cell lineage388 Cell Reports 2, 386–396, August 30, 2012 ª2012 The Authors(Figures S2A and S2B). Importantly, when R26MASTR/+ males
were crossed with R26+/lox-lacZ females, only rare b-gal+ cells
were seen in R26MASTR/lox-lacZ mice (Figures 2C and 2D). Thus,
although GFPcre is expressed spuriously in the male germ cell
lineage from the R26MASTR allele in the absence of FLP activity,
GFPcre protein is not transmitted to the fertilized egg.
To test the second critical component of the MASTR
approach, whether a high percentage of GFP+ cells carry
a deleted (mutant) floxed allele, we assessed the degree towhich
cells in CAG-FlpeER/+; R26MASTR/lox-lacZ mice coexpress GFP
and b-gal on successive days after Tm administration. In
CAG-FlpeER/+; R26MASTR/lox-lacZ embryos administered Tm
(225 mg/g) at E13.5, efficient mosaic marking and mutation of
cells (GFP and b-gal double staining) was achieved within
24 hr (90% of GFP+ cells expressed b-gal; n = 1,435 cells;
n = 4 embryos), with a similar percentage of double-marked cells
at 48 hr (n = 855 cells; n = 3 embryos), and an even higher
percentage by 72 hr (97% of GFP+ cells expressed b-gal;
n = 903 cells; n = 3 embryos) (Figure 2F). In a separate experi-
ment in which embryos were administered Tm at E12.5, 98%
Figure 2. Validation of the MASTR
Approach
(A) Schematic showing strategy used to validate
the approach. Blue dots represent b-gal protein.
(B) Sagittal sections of adult R26MASTR/lox-lacZ brain
show b-gal+ cells throughout the brain when TM is
administered at E13.5 and E14.5 (125 mg/g).
(C) Quantification of number of b-gal+ cells per
R26MASTR/lox-lacZ adult brain section.
(D) Only rare cells are b-gal+ in control
R26MASTR/lox-lacZ adult tissues or embryos, as
shown in sagittal section of the adult brain. Inset
shows high magnification of the region indicated
that has a few b-gal+ cells (indicated by arrows).
(E) Double labeling for GFP and b-gal of a control
R26MASTR/lox-lacZ embryo section shows that GFP
is not detected in b-gal-expressing cells, or any
other cells. Arrow indicates a single b-gal+ cell.
(F) Graph showing the percentage of cells in the
midbrain and anterior hindbrain that coexpress
GFP and b-gal in CAG-FlpeER/+; R26MASTR/lox-lacZ
embryos at the times indicated after administration
of Tm at E13.5.
Error bars indicate ±SD of the average per-
centage. Scale bars represent 400 mm (B and D),
100 mm (inset of D), and 60 mm (E).
See Figures S2 and S5.of GFP+ cells expressed b-gal after 72 hr (n = 561 cells; n = 2
embryos) (Figures S2C–S2E). To determine whether all GFP+
cells eventually have detectable b-gal activity, P21 mice were
administered Tm on 3 consecutive days and then analyzed
3–5 weeks later. Similar to our analysis of embryos at 72 hr
post Tm, 98% of adult cells coexpressed GFP and b-gal
(n = 1,083 cells from three mice). Importantly, these experiments
demonstrate that mosaic mutant cells can be identified within
24 hr based on GFP expression with near-complete concor-
dance by 72 hr using the MASTR approach.
MASTR Approach Reveals Insights into FGF8 and SHH
Signaling
We next used our MASTR approach to gain insight into two well-
studied signaling pathways: fibroblast growth factor (FGF), and
sonic hedgehog (SHH). First, we studied the cell-autonomous
requirement for FGF8 signaling in small cohorts of cells in the
developing dorsal midbrain and cerebellum. FGF receptor 1Cell Reports 2, 386–396(FGFR1) was previously shown to be
required downstream of the isthmic orga-
nizer molecule FGF8 for cell survival,
based on conditional deletion of FgfR1
or Fgf8 in all cells of the midbrain and
cerebellum at E8.5 using an En1Cre allele
(Chi et al., 2003; Trokovic et al., 2003).
We recently found, however, that when
Fgf8 is conditionally ablated 1 day later
using an En2CreER allele, cell survival is
not significantly compromised in the
midbrain and cerebellum (Sato and Joy-
ner, 2009), suggesting that FGF8 is only
transiently required for cell survival.Because Fgf8 or FgfR1 was removed in all cells of the region
at E8.5 using En1Cre, whereas using the En2CreER allele the
Fgf8 gene was ablated in only 80% of cells at E9.5, it is
possible that the cell survival seen in the latter study is due to
rescue by low-level FGF8 signaling provided by the WT cells
that remained.
In order to distinguish between the two possibilities, we
utilized the MASTR approach to test whether FgfR1 is required
for cell survival in individual cerebellum and dorsal midbrain
cells near the isthmus. Indeed, by analyzing CAG-FlpeER;
R26MASTR/+; FgfR1/lox embryos treated with Tm (200 mg/g) at
E8.5 or E9.5, we found that FGF8 signaling through FGFR1 is
required for survival of individual cells only within a narrow time
window. Deletion of FgfR1 by administering Tm at E8.5 resulted
in a >50% reduction in GFP+-marked cells within the dorsal
posterior midbrain and cerebellum at E11.5 compared to CAG-
FlpeER; R26MASTR/+; FgfR1+/lox controls using the ventral poste-
rior hindbrain to normalize for differences in recombination, August 30, 2012 ª2012 The Authors 389
Figure 3. Deletion of FgfR1Only when FGF8
Is First Expressed Results in Loss of Cells
Near the Isthmus Organizer
(A–D and A0–D0) Midline sagittal sections of
the dorsal midbrain/hindbrain region of control
CAG-FlpeER; R26MASTR/+; FgfR1+/lox (A0 and C0)
and mosaic mutant CAG-FlpeER; R26MASTR/+;
FgfR1-/lox mosaic mutant (B0 and D0) embryos
3 days after administration of Tm at E8.5 or E9.5,
respectively. (A)–(D) show midline ventral hind-
brain regions of the respective brains in (A0)–(D0)
used to normalize for variability in recombination
efficiency. Embryos were stained by IHC for GFP
(green) and the midbrain marker OTX2 (red) and
counterstained with DAPI (blue).
(E) Section of E12.5 control brain (CAG-FlpeER;
R26MASTR/+; FgfR1+/lox) showing areas quantified
in (F). dm, posterior dorsal midbrain; cb, cere-
bellum; vh, posterior ventral hindbrain.
(F) Normalized GFP+ cells are represented as
number of GFP+ cells/mm2 in the demarcated area
encompassing the cb and dm divided by the
number of GFP+ cells/mm2 in the demarcated area
encompassing the vh multiplied by 100. ***p =
0.001 for the control compared to themutant when
Tm was administered to E8.5 embryos. p Value is
0.30 when Tm was administered to E9.5 embryos.
Error bars indicate mean ± SD.
Scale bar represents 100 mm.efficiency (n = 3 controls and 3 mosaic mutants; Figures 3A, 3A0,
3B, 3B0, 3E, and 3F). In contrast, when Tm was administered at
E9.5 no significant decrease in cell survival of GFP+-marked
FgfR1 mutant cells was observed 3 days later (n = 3 controls
and 3mosaicmutants; Figures 3C, 3C0, 3D, 3D0, and 3F). Consis-
tent with the results seen at E11.5, few marked cells were
present in the posterior midbrain or cerebellum at E17.5 when
Tm was administered at E8.5 (n = 2) (data not shown). Thus,
using MASTR, we demonstrate that FGF8 signaling through
FGFR1 is only transiently required for cell-autonomous viability
in the developing posterior midbrain and cerebellum.
We next asked whether SHH signaling is required continu-
ously in proliferating granule cells of the postnatal cerebellum.
SHH is secreted by Purkinje cells of the cerebellum from E17.5
onward and signals to granule cell precursors (gcps) and390 Cell Reports 2, 386–396, August 30, 2012 ª2012 The AuthorsBergmann glia (Fuccillo et al., 2006).
Previous studies found that ablation of
the SHH receptor SMO in all cells of the
embryonic cerebellum using a Nestin-
Cre transgene resulted in a dramatic
decrease in the number of granule neu-
rons (Corrales et al., 2006). Because
gain-of-function studies have shown that
SHH stimulates gcp proliferation, it has
been assumed that the defect in Nestin-
Cre; Smolox/mice is due to a cell-auton-
omous effect in gcps, possibly leading to
loss of proliferation, cell death, or prema-
ture differentiation. In order to test a cell-
autonomous function of SMO in gcps, weused MASTR to ablate Smo and examined the phenotype in the
granule cell lineage. When Tm (150 mg/g) was administered to
CAG-FlpeER; R26MASTR/+; Smo/lox mice at P1 or P2 and the
cerebellum analyzed at P8, a clear defect in gcps was seen (Fig-
ures 4A–4E).Whereas in control mice (CAG-FlpeER; R26MASTR/+;
Smo+/lox or CAG-FlpeER; R26MASTR/+; Smo-/+) many GFP+ gcps
were present in the proliferating outer layer of the external
granule cell layer (EGL) (43 GFP+ cells in lobule X per section;
Figures 4A, 4B, and 4F), in CAG-FlpeER; R26MASTR/+; Smo/lox
mutant cerebellamost sections had noGFP+ gcps. Interestingly,
GFP+ mutant cells were present but expressed p27, a marker of
postmitotic granule neurons (Figures 4C–4F). Thus, SHH is
required cell autonomously in gcps tomaintain them in a prolifer-
ating and undifferentiated state. Taken together, our two studies
of the cell-autonomous requirements for FGFR1 and SMO
Figure 4. Deletion of Smo in gcps of the Cerebellum Results in Premature Differentiation
(A–E) Midline sagittal sections of cerebellum showing lobule X in control, CAG-FlpeER; R26MASTR/+; Smo+/lox (A), or CAG-FlpeER; R26MASTR/+; Smo+/ (B), and
mosaic mutant, CAG-FlpeER; R26MASTR/+; Smo-/lox (C–E), embryos treated with Tm on P1 (n = 1 control and 4 mutants) or P2 (n = 1 control and 1 mutant) and
analyzed at P8 for expression of GFP (green) and p27/Kip1 (red), a marker for postmitotic granule cells. Blue indicates DAPI staining. White arrowheads in (E)
indicate rare gcps that express GFP but not p27 (GFP+/p25) found in one out of five mutants.
(F) Quantification of the average number of GFP+ Smomosaic mutant granule cells in the outer EGL of lobule X containing proliferating progenitors (15 sections
were analyzed from mutants and 6 for controls).
Scale bar represents 60 mm.demonstrate the utility of the MASTR approach for uncovering
cell behaviors altered when key signaling pathways are
disrupted.
Generation of an Efficient Universal FLPo-Inducible
Mouse Line and Lineage-Specific FLPoER Transgenic
Mice
We sought to develop a line of mice in which FLP can be
efficiently activated in all tissues because the efficiency of
recombination of the CAG-FlpeER transgenic line was found
to be low in most adult tissues and not effective in the spleen
or skin (Figure 5; Table S1). Given the recent demonstration
that a FLPe construct optimized for translation in mammalian
cells (termed FLPo) has a higher recombination efficiency than
FLPe in cells and in mice (Kranz et al., 2010; Raymond and
Soriano, 2007, 2010), we generated two constructs in which
FLPo and ERT2 were joined by either the linker sequence in
FLPeERT2 (FlpoER), which was found to be effective for Flpe
(Hunter et al., 2005; Logie et al., 1998), or the linker in CreERT2
(FlpoER1). We then generated universal inducible Flpo mouse
lines by targeting each cDNA to the R26 allele in ES cells
(Figures 5A and S1B). To ensure high expression levels, the
constructs were placed downstream of a CAG promoter and
enhancer (Zong et al., 2005).
The efficiency of recombination of the R26FlpoER and
R26FlpoER1 alleles was compared to each other and to CAG-
FlpeER at E9.5, P1, and in adult organs using aR26frt-STOP-frt-nlacZ
nuclear b-gal reporter allele (R26
frt-nlacZ
; derived from RC::Fela;Jensen et al., 2008) or GFP expression from the recombined
R26MASTR allele (data not shown). FLP activity was induced by
Tm in all organs using the R26 alleles and, importantly, was con-
sistent between animals within each stage and organ, although
the extent of recombination was specific to each organ and
stage of induction (Figures 5B–5Q and S3; Table S1). Most
strikingly, the R26FlpoER line consistently showed higher recom-
bination in embryonic and adult tissues than the R26FlpoER1 line
and, significantly, only very rare recombination in the absence
of Tm (similar to the R26MASTR allele alone). Furthermore, the
recombination efficiency was higher with the R26FlpoER allele
than the CAG-FlpeER transgene, with the exception of some
regions of the brain (e.g., cerebellum) using the same reporter
and dose of Tm (Figures 5B–5I, 5R–5Y, and S4; Table S1).
Thus, our ubiquitous inducible R26FlpoER line with the FLPeERT2
linker sequence combined with R26MASTR can be used for
mosaic mutant analysis of floxed genes expressed in any tissue
at any time during development or in the adult.
Because for many mosaic mutant studies in mice it will be
optimal to mark and mutate cells in specific cell lineages or
organs, we generated neural progenitor-specific transgenic lines
expressing FlpoER or FlpoER1 from a Nestin transgene con-
struct (Figure 6A) (Mignone et al., 2004). Consistent with our find-
ings targeting the R26 allele, the FLPoER protein resulted in
higher recombination levels in embryonic and adult brains than
FLPoER1 (Figures 6B–6G). Importantly, recombination was
specific to neural progenitors in the embryo and adult neural
stem cells in the forebrain.Cell Reports 2, 386–396, August 30, 2012 ª2012 The Authors 391
Figure 5. Universal FlpoER-Inducible Lines
of R26 Knockin Mice Reveal the Importance
of the Linker Sequence between FLP andER
(A) Schematic showing R26FlpoER (or R26FlpoER1)
targeted allele. Sections of the tissues indicated
from P35 R26FlpoER/frt-nlacZ derived from CY2.3
ES cells (B–I), R26FlpoER1/frt-nlacZ derived from W4
ES cells (J–Q), or CAG-FlpeER; R26+/frt-nlacZ (R–Y)
mice administered Tm either at P28 (250 mg/g) and
stained for b-gal activity 1 week later (B–E, J–M,
and R–U) or at E9.5 (125 mg/g) and stained for
b-gal activity at E13.5 (F–I, N–Q, and V–Y). Scale
bar in (E) represents 100 mm for all pictures except
(G), (O), and (W), for which scale bars represent
50 mm. See Figures S1, S3, and S4.DISCUSSION
To provide a versatile mosaic mutant analysis approach in
mouse and to overcome major limitations of current conditional
knockout approaches, we utilized the tremendous resource of
floxed conditional alleles (Collins et al., 2007; Ringwald et al.,
2011) and engineered a universally applicable mouse knockin
line (R26MASTR) for controlled mosaic mutant analysis. In our
MASTR approach, floxed genes are conditionally mutated in
mosaic cells and simultaneously marked with GFP under both
temporal and tissue or cell-type-specific (spatial) control. An
essential second component of the system is mouse lines ex-
pressing an inducible FLP recombinase to provide the specificity
of CRE-mediated recombination of floxed alleles. Cells express-
ing active FLP rapidly express a GFPcre fusion protein due to
deletion of an frt-flanked STOP sequence upstream of GFPcre
within the R26MASTR allele. Any floxed gene in the cell is subse-
quently rapidly deleted (>90% of cells by 24 hr and 97% by
72 hr). Specific tissues are targeted for gene deletion by
choosing an appropriate promoter, and temporal control over392 Cell Reports 2, 386–396, August 30, 2012 ª2012 The AuthorsFLP activity and production of mosaics
is provided by using an inducible FLP.
Because we found that FLPeERT2 did
not induce efficient recombination in
mice (unpublished data based on a R26
knockin line and transgenic mice), we
constructed and compared the efficiency
of two inducible proteins based on a
FLPo backbone. Interestingly, we found
that the linker sequence between FLPo
and ERT2 impacts on the efficiency
of recombination and that the linker in
FLPeERT2 (Hunter et al., 2005; Logie
et al., 1998) is optimized for regulating
FLP proteins, compared to the linker in
CreER (Feil et al., 1997). Moreover,
our R26FlpoER allele using the FLPeERT2
linker can be used in combination with
R26MASTR for mosaic mutant studies in
any tissue and at any time during devel-
opment or in the adult.Using the R26MASTR allele and a R26lox-lacZ allele to mimic
a floxed gene, we found that less than 3% of GFP+ cells are
WT (b-gal) 72 hr after Tm administration and, importantly,
that false negatives (GFP/b-gal+) are extremely rare (1 in
1 million cells because the mouse brain contains 100 million
cells; Herculano-Houzel and Lent, 2005). Some of the observed
rare false-positive cells could be true positives falsely character-
ized asWT because of limitations in IHC sensitivity. Alternatively,
some could be WT cells that are resistant to recombination by
the continuously expressed GFPcre, possibly due to the chro-
matin structure of the floxed allele. This is an inherent problem
using any floxed allele, and the degree of resistance to recombi-
nation will have to be determined empirically for every allele and
each genetic background. Nevertheless, our mosaic deletion of
both FgfR1 and Smo functionally validates the MASTR tech-
nique, as well as an additional gene that we used the MASTR
approach for. In order to induce constitutive canonical WNT
signaling in the spinal cord at E7.5, we conditionally deleted
exon 3 of the b-catenin gene (Harada et al., 1999) and found
that 98% of GFP+ cells at E10.5 mis-expressed MSX1/MSX2
Figure 6. Generation of Neural-Specific
Mouse Lines Expressing Inducible Flpo
(A) Schematic diagram of transgene construct
containing FlpoER (or FlpoER1) and Nestin gene
regulatory elements used to make transgenic
lines of mice. Sagittal brain sections of E13.5
Nestin-FlpoER; R26frt-nlacZ/+ (B) and Nestin-
FlpoER1; R26frt-nlacZ/+ (C) embryos administered
Tm (125 mg/g) at E9.5 and stained for b-gal activity.
Control Nestin-FlpoER; R26frt-nlacZ/+ brain from
P3 mouse not administered Tm is shown in (D).
Coronal brain sections from a Nestin-FlpoER;
R26frt-nlacZ/+ adult mouse (E–G) 1 month after
administering two doses of Tm (250 mg/g). b-Gal-
expressing cells are primarily seen in the olfactory
bulb (OB; in E), rostral migratory stream (RMS, box
and inset in F), and subventricular zone (SVZ) of
the fourth ventricle of the forebrain (box and inset
in G). Scale bars represent 200 mm (B, C, F, andG),
400 mm (D), 100 mm (E), 25 mm (inset in F), and
50 mm (inset in G).in the ventral spinal cord compared to normal embryos in which
only rare cells expressed MSX1/MSX2 (unpublished data).
Thus, MASTR will likely be applicable to the vast majority of con-
ditional alleles. One possible drawback to the MASTR approach
is that CRE might be toxic to some cells (Legue´ and Joyner,
2010), despite the relatively low expression level from the R26
locus. Importantly, we did not observe a high level of cell death
in midgestation control embryos (CAG-FlpeER; R26MASTR/+;
FgfR1+/flox), and mice expressing GFPcre in most cells appear
normal (Figure S5).
Using the MASTR approach to study FGF signaling in the
developing brain, we uncovered that FGF8 signaling through
FGFR1 is only transiently required for cell viability in the dorsal
midbrain and cerebellum. Our mosaic mutant results also
provide further support that FGFR1 is the primary receptor for
FGF8 functioning near the isthmus (Saarima¨ki-Vire et al.,
2007) and demonstrate the exquisite sensitivity of individual
cells to a reduction in FGF8 signaling in a time-dependent
manner. Our results shed new light on the interpretation of a
previous study of FgfR1/lox; En1Cre conditional mutant em-
bryos in which cell death was observed near the isthmus within
1 day of FgfR1 deletion at E8.5 (Trokovic et al., 2003) and
suggest that later deletion in the midbrain and cerebellum
would not lead to cell death. Consistent with this, FGF8 has
later roles in regulating expression of key genes involved
in midbrain and cerebellum development (Sato and Joyner,
2009). The cellular consequences of altering FGF8-regulated
genes can now be studied using the MASTR approach. Further-
more, these functional studies demonstrate the power of the
MASTR technique in assessing the critical nature of the timingCell Reports 2, 386–396of gene action and the cell-autonomous
role of genes within the mouse.
The MASTR approach will not only be
a powerful approach for determining the
function of genes based on mutant cell
behaviors during development and in
adult stem cells but also can be used tomodel mosaic human diseases. One of the most prevalent
examples of mosaic disease is sporadic cancer. Although the
importance of modeling sporadic cancers with a mosaic mutant
approach has been demonstrated using a line of mice in which
the MADM allele is on chromosome 11, which harbors a number
of known tumor suppressor genes (Liu et al., 2011; Muzumdar
et al., 2007), with the MASTR approach any cancer can be
modeled using floxed alleles of the key tumor suppressors
and/or oncogenes. Furthermore, because the tumor cells are
GFP labeled using MASTR, a pure population of tumor cells
can be isolated for further biochemical and genomic analysis.
In summary we have developed and validated a method for
mosaic mutant analysis in mice that combines sequential
expression of an engineered inducible FLPoER protein with sus-
tained conditional expression of GFPcre and deletion of floxed
genes. Moreover, we have demonstrated the importance of
controlling the time and cell type of mutagenesis in mosaic
studies. The R26MASTR allele can also be used to convert the
growing number of tissue and cell-type-specific Flp lines of
mice into Cre lines, with the added advantage that mutant cells
are marked with GFP (Figure S5). Finally, new versions of the
R26MASTR allele can now be designed that coexpress CRE and
any marker protein, for example using the viral 2A peptide
(Trichas et al., 2008). As additional inducible site-specific recom-
binases are generated, such as using DRE (Anastassiadis et al.,
2009), they could be used in combination with FLPoER to induce
GFPcre expression in a more defined cell population using
intersectional genetics (Dymecki et al., 2010). Thus, we have
described the first critical step in a far-ranging approach to
mutant mosaic analysis in mouse., August 30, 2012 ª2012 The Authors 393
EXPERIMENTAL PROCEDURES
Construction of Mice Carrying a R26MASTR Allele
All experiments were conducted according to protocols approved by the
Memorial Sloan-Kettering Cancer Center Animal Care and Use Committee.
A R26MASTR-targeting vector was constructed that consists of a 1 kb 50 arm
of homology from the first intron of the R26 allele ending at an XbaI site
(Soriano, 1999), followed by an SV40 splice acceptor (Zambrowicz et al.,
1997), frt-flanked Pgk-neo cassette with a strong Pgk-derived polyA
sequence, eGFPcre cDNA (from pBS594; Le et al., 1999), three copies of
a 250 bp SV40 polyA sequence (Bai and Joyner, 2001), and adjacent 4 kb 3
0
arm of homology from the first intron of the R26 allele (Soriano, 1999). The
vector was then linearized with SalI and targeted into the R26 locus in mouse
129SvEv Tac W4 ES cells (Auerbach et al., 2000) and chimeras produced by
blastocyst injection using standardmethods (Matise et al., 2005; Papaioannou
and Johnson, 2005). Germline-transmitting chimeras were bred with 129SvEv
Tac mice, and sperm from the resulting mice was frozen. For all studies
reported, chimeras were bred with C57bl/6 mice and then F1 mice were
bred with outbred Swiss Webster (SW) mice or mice carrying reporter alleles
that had been bred with SW mice.
Production of R26frt-nlacZ Line
The R26frt-nlacZ line (previously described as RC::Fa in Jensen et al., 2008) was
generated bymatingR26frt-STOP-frt-lox-GFP-lox-nlacZmice (RC::Fela; Jensen et al.,
2008) with a CAG-Cre deleter line (Sakai and Miyazaki, 1997) to remove a
loxP-flanked Gfp cassette, resulting in a reporter allele that expresses nuclear
localized LACZ (nlacZ cDNA) following FLP-mediated recombination of an
frt-flanked neo STOP cassette.
Construction of FlpoER cDNAs
A cDNA construct encoding FLPoER1 was produced by fusing a DNA
sequence encoding an optimized FLP obtained from Addgene (Raymond
and Soriano, 2007) to the linker and ERT2 sequence in CreERT2 (bp 2,082–
2,090) (Feil et al., 1997). FlpoER was produced by replacing the linker se-
quence in FlpoER1 (CTCGAGCCA) with the linker sequence (TGCGTACGCG
GATCC) from FlpeER (Hunter et al., 2005; Logie et al., 1998).
Gene-Targeting Strategy for Universal FlpoER and FlpoER1-
Inducible Alleles in the R26 Locus
A cassette containing a loxP-flanked Pgk-neo cassette was subcloned into the
SwaI site of a plasmid (pCA(HZ2)) containing a CAG promoter sequence (Zong
et al., 2005), and FlpoER or FlpoER1was then cloned downstream of the CAG
promoter sequence in a SmaI site. A targeting construct was then constructed
using the R26 genomic fragments described above (Soriano, 1999) in order to
target each vector into the XbaI site in the first intron. The vector was then line-
arized with SalI, and the FlpoER construct was targeted into the R26 locus in
mouse 129SvEv TacW4 ES cells (Auerbach et al., 2000) and CY2.3 cells (gift of
the Rockefeller Gene Targeting core), and the FlpoER1 construct was targeted
into W4 ES cells. Chimeras were then produced by blastocyst injection using
standard methods (Matise et al., 2005; Papaioannou and Johnson, 2005).
Germline-transmitting chimeras were bred with 129SvEv Tacmice, and sperm
from the resulting mice was frozen. For all studies reported, chimeras were
bred with C57bl/6 mice and then F1 mice were bred with outbred SW mice
or mice carrying reporter alleles that had been bred with SW mice. R26FlpoER
mice derived from W4 or CY2.3 ES cells gave similar recombination results
(compare Figures 5 and S3).
The recombination efficiency of FLPoER and FLPoER1 was compared in
R26FlpoER/+ or R26FlpoER1/+ mice carrying Gfp or nlacZ conditional reporters
(R26MASTR or R26frt-nlacZ) by analyzing GFP by IHC or b-gal activity by X-gal
analysis. E13.5 embryos were analyzed after treatment with Tm (125 mg/g) at
E9.5, P6 mice treated with Tm (150 mg/g) on P1, or adult mice treated with
Tm (250 mg/g), and brains were analyzed 1 week later (n = at least 3 for each
time point).
Construction of Nestin-FlpoER Transgenic Mice
A 2.3 kb SalI/SpeI FlpoER or FlpoER1 fragment was subcloned into the SalI/
XbaI sites of a rat Nestin expression construct that contains promoter394 Cell Reports 2, 386–396, August 30, 2012 ª2012 The Authorssequences and the second intron (Mignone et al., 2004). The FlpoER or
FlpoER1 cDNA was inserted between the promoter and intron sequences,
and followed by one copy of a 250 bp SV40 polyA site. SmaI was used to
release the Nestin-FlpoER-SV40 polyA fragment, which was used for pronu-
clear injections of fertilized oocytes.
A total of 66 animals born after injection of Nestin-FlpoER1 and 52
after injection of Nestin-FlpoER was screened by PCR using the primers
50-GCTTCCGCTGGGTCACTGTCGC-30 (corresponding to a sequence in the
Nestin promoter gene) and 50-ATCATCCAGCACAGGTAGGTCAGC-30 (corre-
sponding to a sequence in the FlpoER cDNA). The expected fragment of
300 bp was detected in 11 Nestin-FlpoER1 founder (F0) and 10Nestin-FlpoER
F0 transgenic mice. Seven of the F0 Nestin-FlpoER1 and five of the Nestin-
FlpoER mice transmitted the transgene to their F1 offspring. F1 males from
each line were screened for transgene activity by mating with R26MASTR or
R26frt-nlacZ females. Embryonic ages were determined as the time since the
appearance of a copulative plug (noon of the first day was determined as
E0.5). Tm was administered on E9.5, and embryos were analyzed at E13.5
for GFP and b-gal expression. GFP+ or b-gal+ cells were detected in the devel-
oping nervous system of all the Nestin-FlpoER1 lines, and four of five Nestin-
FlpoER lines were tested. Only one Nestin-FlpoER1 line showed a few GFP+
cells in the absence of Tm. Lines were further screened for expression in the
adult brain by administering Tm on 2 or 3 consecutive days and analyzing brain
sections 1month later. GFP+ cells were detected in the ependymal cell layer of
the subventricular zone of the fourth ventricle in all lines. The one Nestin-
FlpoER and Nestin-FlpoER1 line that gave the highest amount of recombina-
tion in the presence of Tm and no recombination in the absence of Tm was
chosen for detailed analysis. The efficiency of recombination of the Nestin-
FlpoER1 transgene appeared to be similar to that of R26FlpoER when Tm
(125 mg/g) was administered at E9.5 (with variations in different regions of
the brain), and the Nestin-FlpoER line gave much higher recombination in
embryos.
Histology, Immunohistochemistry, and X-Gal Staining
Tissue processing and X-gal analysis were performed as described on the
Joyner website (http://www.mskcc.org/mskcc/html/77387.cfm). Frozen sec-
tions were prepared at a thickness of 12 mm. Immunofluorescent histochem-
istry (IHC) was performed using standard staining procedures with the
following primary antibodies: goat-anti-b-gal (1:1,500; Biogenesis); rabbit-
anti-GFP (1:1000; Invitrogen); rat-anti-GFP (1:1,000; Nacalai Tesque);
mouse-anti-p27/KIP1 (1:500; BD Biosciences); goat-anti-OTX2 (1:500; R&D
Systems); and secondary antibodies: donkey anti-goat-Alexa 555, donkey
anti-rabbit-Alexa 488, donkey-anti-rat-Alexa 488, and donkey-anti-goat-Alexa
555 (1:1,000; Invitrogen).
Quantification and Statistics
To determine the number of cells that underwent recombination in the absence
of Tm, the number of b-gal+ cells on each of 138 entire sagittal brain sections
from 5 adult R26MASTR/lox-lacZ mice was counted and then the results of each
slide were binned into groups of 5 (0–5, 6–10, etc.) and graphed (Figure 2C).
In order to determine the percentage of GFP+ cells that also carry a mutant
floxed allele, we quantified the number of cells in CAG-FlpeER/+;
R26MASTR/lox-lacZ mice that coexpressed GFP and b-gal 24, 48, and 72 hr after
Tm administration (225 mg/g). The 12 mm sagittal sections of embryos at each
stage (1 section/embryo, n = 3–4 embryos per stage) were double stained for
GFP and b-gal protein, and the number of single- and double-labeled cells was
counted in the midbrain and anterior hindbrain (855–1,435 cells counted at
each stage). The percentage of b-gal+ cells that also expressed GFP was
then calculated (Tm 24 hr, 90% ± 1.7%, n = 4; Tm 48 hr, 92% ± 0.9%,
n = 3; Tm 72 hr, 97% ± 1.9%, n = 3) (Figure 2F). Statistical analysis was per-
formed using Microsoft Excel to calculate mean and SD (mean ± SD).
Quantification of GFP+ cells inmosaicmutant FgfR1lox (Trokovic et al., 2003)
embryos was performed after IHC staining for GFP and OTX2 on 12 mm frozen
sections at E11.5 and E12.5 of control CAG-FlpeER; R26MASTR/+; FgfR1+/lox
and mutant CAG-FlpeER; R26MASTR/+; FgfR1/lox embryos 3 days after Tm
administration, as shown in Figure 3. Images were imported into Neurolucida
software (MBF Biosciences) and quantified as follows. The quantified area
included the OTX2 region within the dorsal hindbrain encompassing the
cerebellumand theareawithin thedorsalposteriormidbraindefinedasa100mm
distance anterior from the dorsal midbrain-cerebellum boundary defined by the
abrupt cutoff in OTX2 expression (Figure 3E). To control for recombination
efficiency between embryos, GFP+ cells/mm2 in the dorsal midbrain and cere-
bellumwerenormalized to thenumber ofGFP+cells/mm2 in the ventral posterior
hindbrain, a region that is not sensitive to FgfR1 loss (Figure 3E). The data are
presented as the number of GFP+ cells/mm2 in the dorsal midbrain and cere-
bellum divided by the number of GFP+ cells/mm2 in the ventral hindbrain region
and multiplied by 100. A minimum of 300 GFP+ cells was counted for each
region for control and mutant embryos at E12.5, and a minimum of 100 GFP+
cells was counted for E11.5 embryos due to smaller area and lower recombina-
tion at this stage. Statistical analysis was performed using Apple Numbers soft-
warewithmeanandSDcalculated (n=3 for control andmutant embryosat each
time point), and p values were calculated using a Student’s unpaired t test.
Quantification of GFP+ cells in the outer EGL of lobule X of the cerebellum of
mosaic mutant Smolox (Long et al., 2001) embryos was performed after IHC
staining for GFP and p27 on 12 mm frozen sections (15 mutant sections and
6 control sections) at P8 in control mice, CAG-FlpeER; R26MASTR/+; Smo+/lox
(n = 1) orCAG-FlpeER; R26MASTR/+; Smo+/ (n = 1), andmutants,CAG-FlpeER;
R26MASTR/+; Smo/lox (n = 5), 6–7 days after Tm administration.
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